If you have trouble reading this email, go to http://www.biocompare.com/newsletters/6771.html

Cancer E-Newsletter from Biocompare
News and New Technologies from the Buyer's Guide for Life Scientists
Sponsored by Exiqon

microRNA ISH Service
Exiqon, the leader in microRNA ISH, now offers ISH screening services on FFPE samples with our groundbreaking LNA™-enhanced probes. The Exiqon OptiScreen ISH Service provides protocol optimization, screening, a detailed results report, and a CD of publication-ready ISH images at 20X magnification. Exiqon offers complimentary full consultation and guidance from our highly-trained scientific staff throughout the entire project, ensuring the highest level of attention and support for your experiment.
more...
Featured Article
Biomarker Discovery
Imagine if you could peer into the proteome of your child and see raised warning flags denoting the future development of various diseases. Hopefully there would be something you could do to prevent those maladies. We can’t yet do all of this, but we are making progress on using proteins as biomarkers for...more...
Featured Article
LIMS (Laboratory Information Management Systems)
Automation used to be found in only the largest biotech and pharmaceutical laboratories. Today, however, it is part of the workflow in all types of laboratories: small and large, academic as well as industrial. Whether you use an automated system for...more...
News

Cells Of Aggressive Leukemia Hijack Normal Protein To Grow, According To Penn Study
more...

News Brief: Poorer Breast Cancer Survival Associated With Micrometastases In Axillary Lymph Nodes
more...

Effective Prostate Cancer Treatment Discovery
more...

Notch-Blocking Drugs Kill Brain Cancer Stem Cells, Yet Multiple Therapies May Be Needed
more...

New Cancer-Fighting Strategy Focuses On Signaling Molecules
more...

The Sound Of Melanoma Can Help Doctors Find Cancer
more...

Mayo Clinic Researchers Find Oncogene Is Important In Pancreatic Cancer Growth And Spread
more...

SIBLING Proteins May Predict Oral Cancer
more...

Mayo Oral Cancer Study Shows Full Tumor Genome
more...

Arsenic Exposure Activates An Oncogenic Signaling Pathway; Leads To Increased Cancer Risk
more...

Bitter Melon Extract Decreased Breast Cancer Cell Growth
more...

What It Might Take To Unravel The 'lean Mean Machine' That Is Cancer
more...

Synthetic Lethality: A New Way To Kill Cancer Cells
more...

New DNA Technique Leads To A Breakthrough In Child Cancer Research
more...

Blocking Blood Vessel Formation Prevents Brain Tumor Recurrence In Mice
more...

New Treatment To Prevent Cancer Recurrence Shows Promise In Stanford Study
more...

Researchers Identify A Potential Therapeutic Target For Brain Cancer
more...

New Technologies
Antigenix America Inc. - Super-X™ Cytokine ELISA Kits
ANTIGENIX AMERICA offers our Super-X™ Cytokine ELISA kits.
more...
Calbiotech, Inc - Mouse/Rat ELISA Kits
Calbiotech offers unique Mouse/Rat ELISA kits for the quantitative measurement of a range of biomarkers such as ACTH, Cotinine, Prolactin,T3, T4, DHEA-S, Estradiol, Troponin I and HSV-1 IgG and others.
more...
Promotion

Receive a 20% Discount on Hematology Reagents for the Study of Plasmin Activation
For a limited time, Cell Sciences is offering a 20% discount on selected products useful in the investigation of plasmin activation. These include PAI-1, tPA, uPA, uPAR, Vitronectin and related proteins and ELISA kits. Plasminogen Activator Inhibitor 1 (PAI-1) plays a key role in fibrinolysis through its regulation of Tissue-type (tPA) and Urokinase-type Plasminogen Activators (uPA). Plasminogen is the inactive zymogen of plasmin, the protease responsible for degrading fibrin. The intricacies of the PAI-1-Plasminogen Activator-Plasmin system and its regulation are being investigated in renal and cardiovascular disease, in addition to inflammation, angiogenesis, and cancer.More Information
Product Review
Product Review: EasySep® Human CD34 Positive Selection Kit From StemCell Technologies
Hematopoietic stem cells (HSC) are cells that are capable of giving rise to progenitors leading to both cells of lymphoid origin such as T cells and B cells, as well as cells of myeloid origins such as macrophages, monocytes, neutrophils and...
more...
Events

Imaging in Oncology
March 10 - March 11, 2010
This year’s conference will focus on a wide range of imaging techniques in a wide range of settings - from the preclinical, to the clinical, to the future of oncological imaging. You will hear presentations from the leading experts in their fields on the latest developments in MRI, PET, SPECT, Raman Sepctroscopy and more.
more...

Discovery Summit 2010
March 22 - March 24, 2010
The Discovery Summit 2010 will highlight the industry’s current challenges and opportunities on a global level through international keynote presentations and case studies delivered by the most esteemed thought leaders in the industry. Within the luxurious settings of The Majestic Barrière, Cannes, this networking event presents a unique opportunity to develop meaningful and valuable business relations.
more...

High Throughput Screening
April 26 - April 27, 2010
SMi's industry-leading High Throughput Screening conference returns for its fourth year. The theme of this year's conference will be how to lead HTS down an intelligent route towards lead generation, and will be discussed and debated by senior representatives from industry and the growing academic HTS sector.
more...

Jobs

Assoc Scientist
Genentech
California USA
more...

Postdoctoral Fellow Positions
The University of Texas M. D. Anderson Cancer Center
Texas USA
more...

Head of Oncology Diagnostics Research
Pfizer
California USA
more...

Director, Protein Engineering
Intrexon Corporation
Maryland USA
more...

Back to Top
Copyright© 1999 - 2010 Biocompare, Inc. All rights reserved.
To unsubscribe, please reply to this message with the word "remove" as the subject.

Biocompare. The 
Buyer's Guide for Life Scientists. ™
Biocompare, Inc.
395 Oyster Point Blvd., Suite 405
South San Francisco, CA 94080